Analytical Data
-
基因名
GLT8D2
- Application
-
别名
Glycosyltransferase 8 domain-containing protein 2; GALA4A
-
种属
Human
-
表达系统
Baculovirus
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9H1C3
-
表达区间
K25-S349
-
蛋白长度
Lumenal Domain
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GLT8D2, or glycosyltransferase 8 domain containing 2, is a member of the glycosyltransferase family, which is known to play critical roles in various biological processes, including cell signaling, protein stability, and immune responses. The study of GLT8D2 is particularly relevant due to its involvement in the synthesis of glycosylated molecules, which are essential for normal cellular function and communication. Recent research has suggested that GLT8D2 may be implicated in several diseases, including cancer, inflammatory conditions, and neurological disorders, making it a potential target for therapeutic interventions. The recombinant protein expression of GLT8D2 allows for in-depth structural and functional analyses, facilitating the understanding of its enzymatic mechanisms and biological functions. Researchers aim to elucidate the protein's role in glycosylation pathways and to explore how alterations in its expression levels might contribute to disease pathology. Furthermore, GLT8D2’s substrate specificity and interaction with other cellular components present exciting avenues for drug development and biotechnological applications. As such, the advancement of GLT8D2 recombinant protein studies represents a promising field of research with implications for both fundamental science and clinical applications.












